Posmodernidad, sociedades adictivas, cannabis y comportamiento suicida: ¿Hacia un mundo feliz?

Hilario Blasco-Fontecilla

Resumen


Editorial del vol. 30-1

Palabras clave


Posmodernidad; sociedades adictivas; cannabis; comportamiento suicida.

Texto completo:

PDF PDF (English)

Referencias


WHO. (2014). Preventing suicide: A global imperative. Ginebra: World Health Organization. 

Agrawal, A., Nelson, E. C., Bucholz, K. K., Tillman, R., Grucza, R. A., Statham, D. J.,… Lynskey, M. T. (2017). Major depressive disorder, suicidal thoughts and behaviours, and cannabis involvement in discordant twins: a retrospective cohort study. Lancet Psychiatry, 4, 706-714. doi:10.1016/S2215-0366(17)30280-8.

Alvarez, A., Gamella, J. F. y Parra, I. (2017). The legalization of cannabis derivatives in Spain: Hypothesis on a potential emerging market. Adicciones, 29, 195-206. doi:10.20882/adicciones.807.

Bilkei-Gorzo, A., Albayram, O., Draffehn, A., Michel, K., Piyanova, A., Oppenheimer, H.,…  Zimmer, A. (2017). A chronic low dose of Delta9-tetrahydrocannabinol (THC) restores cognitive function in old mice. Nature Medicine, 23, 782-787. doi:10.1038/nm.4311.

Blasco-Fontecilla, H. (2012). The addictive hypothesis of suicidal behavior. Medical Hypotheses, 78, 350. doi:10.1016/j.mehy.2011.11.005.

Blasco-Fontecilla, H. (2014). Medicalization, wish-fulfilling medicine, and disease mongering: toward a brave new world? Revista Clinica Española, 214, 104-107.

Blasco-Fontecilla, H. (2017). Hacia un mundo feliz. Madrid: Libros.com.

Blasco-Fontecilla, H., Artieda-Urrutia, P., Berenguer-Elias, N., Garcia-Vega, J. M., Fernandez-Rodriguez, M., Rodriguez-Lomas, C.,… de Leon, J. (2014). Are major repeater patients addicted to suicidal behavior? Adicciones, 26, 321-333.

Blasco-Fontecilla, H., Baca-García, E., Courtet, P., García Nieto, R. y de Leon, J. (2015). Horror Vacui: Emptiness Might Distinguish between Major Suicide Repeaters and Nonmajor Suicide Repeaters: A Pilot Study. Psychotheraphy and Psychosomatics, 84, 117-119.

Blasco-Fontecilla, H., Fernandez-Fernandez, R., Colino, L., Fajardo, L., Perteguer-Barrio, R. y de Leon, J. (2016). The Addictive Model of Self-Harming (Non-suicidal and Suicidal) Behavior. Frontiers in Psychiatry, 7, 8. doi:10.3389/fpsyt.2016.00008.

Casajuana, C., Lopez-Pelayo, H., Balcells, M. M., Colom, J. y Gual, A. (2017). Psychoactive constituents of cannabis and their clinical implications: a systematic review. Adicciones, Avance de publicación on-line. doi:10.20882/adicciones.858.

Christensen, R., Kristensen, P. K., Bartels, E. M., Bliddal, H. y Astrup, A. (2007). Efficacy and safety of the weight-loss drug rimonabant: a meta-analysis of randomised trials. Lancet, 370, 1706-1713.

Claudet, I., Mouvier, S., Labadie, M., Manin, C., Michard-Lenoir, A. P., Eyer, D. y Dufour, D. (2017). Unintentional Cannabis Intoxication in Toddlers. Pediatrics, 140, e20170017. doi:10.1542/peds.2017-0017.

Colino L, Herranz-Herrer, J., Gil-Benito E, Ponte-Lopez T, del Sol-Calderon P, Rodrigo-Yanguas M,… Blasco-Fontecilla H (en prensa). Cannabinoid receptors, mental pain and suicidal behavior: a systematic review. Current Psychiatry Reports. 

Czernin, S., Vogel, M., Fluckiger, M., Muheim, F., Bourgnon, J. C., Reichelt, M.,… Stoppe, G. (2012). Cost of attempted suicide: a retrospective study of extent and associated factors. Swiss Medical Weekly, 142, w13648. doi:10.4414/smw.2012.13648.

de Leon, J., Baca-Garcia, E. y Blasco-Fontecilla, H. (2015). From the serotonin model of suicide to a mental pain model of suicide. Psychotheraphty and Psychosomatics, 84, 323-329. doi:10.1159/000438510.

Devinsky, O., Cross, J. H., Laux, L., Marsh, E., Miller, I., Nabbout, R.,… Wright, S. (2017). Trial of Cannabidiol for Drug-Resistant Seizures in the Dravet Syndrome. The New England Journal of Medicine, 376, 2011-2020. doi:10.1056/NEJMc1708349.

El Marroun, H., Hudziak, J. J., Tiemeier, H., Creemers, H., Steegers, E. A., Jaddoe,… Huizink, A. C. (2011). Intrauterine cannabis exposure leads to more aggressive behavior and attention problems in 18-month-old girls. Drug and Alcohol Dependence, 118, 470-474. doi:10.1016/j.drugalcdep.2011.03.004.

El Marroun, H., Tiemeier, H., Franken, I. H., Jaddoe, V. W., van der Lugt, A., Verhulst, F. C.,… White, T. (2016). Prenatal Cannabis and Tobacco Exposure in Relation to Brain Morphology: A Prospective Neuroimaging Study in Young Children. Biological Psychiatry, 79, 971-979. doi:10.1016/j.biopsych.2015.08.024.

Etges, T., Karolia, K., Grint, T., Taylor, A., Lauder, H., Daka, B. y Wright, S. (2016). An observational postmarketing safety registry of patients in the UK, Germany, and Switzerland who have been prescribed Sativex® (THC:CBD, nabiximols) oromucosal spray. Therapeutics and Clinical Risk Management, 12, 1667-1675.

Freeman, D., Dunn, G., Murray, R. M., Evans, N., Lister, R., Antley, A.,… Morrison, P. D. (2015). How cannabis causes paranoia: using the intravenous administration of 9-tetrahydrocannabinol (THC) to identify key cognitive mechanisms leading to paranoia. Schizophrenia Bulletin, 41, 391-399. doi:10.1093/schbul/sbu098.

Freeman, T. P. y Winstock, A. R. (2015). Examining the profile of high-potency cannabis and its association with severity of cannabis dependence. Psychological Medicine, 45, 3181-3189. doi:10.1017/S0033291715001178.

Garcia del Pozo, J., Carvajal, A., Viloria, J. M., Velasco, A. y Garcia del Pozo, V. (2008). Trends in the consumption of opioid analgesics in Spain. Higher increases as fentanyl replaces morphine. European Journal of Clinical Pharmacology, 64, 411-415.

Hasin, D. S., Sarvet, A. L., Cerda, M., Keyes, K. M., Stohl, M., Galea, S. y Wall, M. M. (2017). US Adult Illicit Cannabis Use, Cannabis Use Disorder, and Medical Marijuana Laws: 1991-1992 to 2012-2013. JAMA Psychiatry, 74, 579-588. doi:10.1001/jamapsychiatry.2017.0724.

Hauser, W., Petzke, F. y Fitzcharles, M. A. (2017). Efficacy, tolerability and safety of cannabis-based medicines for chronic pain management - An overview of systematic reviews. European Journal of Pain. Avance de publicación on-line. doi:10.1002/ejp.1118. doi: 10.1002/ejp.1118.

Huizenga, M. N., Wicker, E., Beck, V. C. y Forcelli, P. A. (2017). Anticonvulsant effect of cannabinoid receptor agonists in models of seizures in developing rats. Epilepsia, 58, 1593-1602. doi:10.1111/epi.13842.

Hurd, Y. L. (2017). Cannabidiol: Swinging the Marijuana Pendulum From ‘Weed’ to Medication to Treat the Opioid Epidemic. Trends in Neurosciences, 40, 124-127. doi:10.1016/j.tins.2016.12.006.

Kaplan, E. H., Offermann, E. A., Sievers, J. W. y Comi, A. M. (2017a). Cannabidiol Treatment for Refractory Seizures in Sturge-Weber Syndrome. Pediatric Neurology, 71, 18-23 e2. doi:10.1016/j.pediatrneurol.2017.02.009.

Kaplan, J. S., Stella, N., Catterall, W. A. y Westenbroek, R. E. (2017b). Cannabidiol attenuates seizures and social deficits in a mouse model of Dravet syndrome. Proceedings of the National Academy of Sciences of the United States of America, 114, 11229-11234. doi:10.1073/pnas.1711351114.

Lipovetsky, G. (1986). La  era del vacío. Barcelona: Anagrama.

Manrique-Garcia, E., Ponce de Leon, A., Dalman, C., Andreasson, S. y Allebeck, P. (2016). Cannabis, Psychosis, and Mortality: A Cohort Study of 50,373 Swedish Men. American Journal of Psychiatry, 173, 790-798. doi:10.1176/appi.ajp.2016.14050637.

Meier, M. H., Caspi, A., Cerda, M., Hancox, R. J., Harrington, H., Houts, R.,… Moffitt, T. E. (2016). Associations Between Cannabis Use and Physical Health Problems in Early Midlife: A Longitudinal Comparison of Persistent Cannabis vs Tobacco Users. JAMA Psychiatry, 73, 731-740. doi:10.1001/jamapsychiatry.2016.0637.

Murray, R. M., Englund, A., Abi-Dargham, A., Lewis, D. A., Di Forti, M., Davies, C.,… D’Souza, D. C. (2017). Cannabis-associated psychosis: Neural substrate and clinical impact. Neuropharmacology, 124, 89-104. doi:10.1016/j.neuropharm.2017.06.018.

Murthy, V. H. (2016). Ending the Opioid Epidemic - A Call to Action. The New England Journal of Medicine, 375, 2413-2415. doi:10.1056/NEJMp1612578.

Rego, P. (2017). Vuelven los zombis (de la heroína). En: El mundo: España. Recuperado de http://www.elmundo.es/cronica/2017/11/09/59ff451fe5fdea662c8b45be.html.

Riba, J., Valle, M., Sampedro, F., Rodriguez-Pujadas, A., Martinez-Horta, S., Kulisevsky, J. y Rodriguez-Fornells, A. (2015). Telling true from false: cannabis users show increased susceptibility to false memories. Molecular Psychiatry, 20, 772-777. doi:10.1038/mp.2015.36.

Rigucci, S., Marques, T. R., Di Forti, M., Taylor, H., Dell’Acqua, F., Mondelli, V.,… Dazzan, P. (2016). Effect of high-potency cannabis on corpus callosum microstructure. Psychological Medicine, 46, 841-854. doi:10.1017/S0033291715002342.

Ruehle, S., Rey, A. A., Remmers, F. y Lutz, B. (2012). The endocannabinoid system in anxiety, fear memory and habituation. Journal of Psychopharmacology, 26, 23-39. doi:10.1177/0269881111408958.

Russo, M., Naro, A., Leo, A., Sessa, E., D’Aleo, G., Bramanti, P. y Calabro, R. S. (2016). Evaluating Sativex® in Neuropathic Pain Management: A Clinical and Neurophysiological Assessment in Multiple Sclerosis. Pain Medicine, 17, 1145-1154. doi:10.1093/pm/pnv080.

Saiz, P. A. y Bobes, J. (2014). Suicide prevention in Spain: An uncovered clinical need. Revista de Psiquiatría y Salud Mental, 7, 1-4. doi:10.1016/j.rpsm.2014.01.003.

Schoeler, T., Petros, N., Di Forti, M., Klamerus, E., Foglia, E., Murray, R. y Bhattacharyya, S. (2017). Poor medication adherence and risk of relapse associated with continued cannabis use in patients with first-episode psychosis: a prospective analysis. Lancet Psychiatry, 4, 627-633. doi:10.1016/S2215-0366(17)30233-X.

Schoeler, T., Petros, N., Di Forti, M., Pingault, J. B., Klamerus, E., Foglia, E., … y Bhattacharyya, S. (2016). Association Between Continued Cannabis Use and Risk of Relapse in First-Episode Psychosis: A Quasi-Experimental Investigation Within an Observational Study. JAMA Psychiatry, 73, 1173-1179. doi:10.1001/jamapsychiatry.2016.2427.

Sophocleous, A., Robertson, R., Ferreira, N. B., McKenzie, J., Fraser, W. D. y Ralston, S. H. (2017). Heavy Cannabis Use Is Associated With Low Bone Mineral Density and an Increased Risk of Fractures. American Journal of Medicine, 130, 214-221.

Tedesco, D., Asch, S. M., Curtin, C., Hah, J., McDonald, K. M., Fantini, M. P. y Hernandez-Boussard, T. (2017). Opioid Abuse And Poisoning: Trends In Inpatient And Emergency Department Discharges. Health Affairs (Millwood), 36, 1748-1753. doi:10.1377/hlthaff.2017.0260.

Walsh, Z., Gonzalez, R., Crosby, K., M, S. T., Carroll, C. y Bonn-Miller, M. O. (2017). Medical cannabis and mental health: A guided systematic review. Clinical Psychological Review, 51, 15-29. doi:10.1016/j.cpr.2016.10.002.

WHO (1999). Figures and facts about suicide. Ginebra: World Health Organization.

Zuardi, A. W., Crippa, J. A., Hallak, J. E., Bhattacharyya, S., Atakan, Z., Martin-Santos, R.,… Guimaraes, F. S. (2012). A critical review of the antipsychotic effects of cannabidiol: 30 years of a translational investigation. Current Pharmaceutical Design, 18, 5131-5140.

Zuil, M., Pascual, A. (2017). Tu madre también se droga (pero con receta). En: El Confidencial: Madrid. Recuperado de https://www.elconfidencial.com/espana/2017-01-22/opioides-ansioliticos-tramadol-oxycontin-alprazolam-diazepam-benzodiacepinas_1319536/




DOI: https://doi.org/10.20882/adicciones.1104

Enlaces refback

  • No hay ningún enlace refback.